diff --git a/Omg%21-The-Best-GLP-1-Ever%21.md b/Omg%21-The-Best-GLP-1-Ever%21.md
new file mode 100644
index 0000000..c911233
--- /dev/null
+++ b/Omg%21-The-Best-GLP-1-Ever%21.md
@@ -0,0 +1,5 @@
+<br> People taking a first-gen [ColonBroom GLP-1](https://wiki.nynox.solutions/index.php/Case_Study:_ColonBroom_-_Revolutionizing_Digestive_Health_With_Natural_Supplements) should use our Points Program since it helps support weight loss with the milder reduction in appetite brought on by those meds. This promotes a feeling of fullness and may help with weight management. Each element works together to optimize metabolism, regulate appetite,  [ColonBroom GLP-1](https://hikvisiondb.webcam/wiki/User:LateshaRizzo3) and create a long-term weight management strategy. A Quality Assurance Unit must exist to assure management that facilities, personnel, practices and  ColonBroom official records are in compliance with regulations, to maintain a master schedule sheet of studies, to inspect each nonclinical study at intervals to assure compliance and to report findings to Study Director and Management,  [ColonBroom GLP-1](https://hikvisiondb.webcam/wiki/SixMethods_You_Should_Use_GLP_To_Turn_Into_Irresistible_To_Prospects) to review the final report to assure that it accurately reflects the raw data, and to prepare and sign a QA statement in the final report. Testing Facility Management must be identified to designate or  [ColonBroom GLP-1](http://youtools.pt/mw/index.php?title=User:PZFDenise02) replace the Study Director, to assure the presence of a Quality Assurance Unit, the characterization of test and control articles, and to assure the presence of adequate personnel, resources, facilities, equipment, materials, and methodologies. Nor do the GLPs pertain to basic exploratory studies carried out to determine whether a test article has any potential utility or, for FDA studies only, to determine physical or chemical characteristics of a test article.<br>
+
+<br> The Good Laboratory Practice regulations describe the minimal standards for conducting nonclinical laboratory studies that support or are intended to support applications for research or marketing permits for products regulated by FDA or EPA such as animal food additives, human and animal drugs, medical devices for human use, biological products, electronic products, or pesticide products. The regulations do not pertain to studies utilizing human subjects or clinical studies for which the current Good Clinical Practice (cGCP) standards would apply. The diverse questions relating to the topic of GLP/GEP and field studies are discussed intensively and illuminated from various sides. Good Laboratory Practices (GLP) embodies a set of principles that provides a framework within which laboratory studies (activities) are planned, performed, monitored, recorded, reported, and archived. The Study Director must be designated as the single source of study control who assures that the protocol is approved and followed, that all experimental data are recorded, that the GLPs are followed, and that all raw data, documentation, protocols, specimens, and final reports are archived. Although it was shocking, it was not surprising that the ‘GLP is a creation of Monsanto’ fiction found its way into the Democrat’s final February 2018 report.<br>
+
+<br> The final report shall contain a compliance statement signed by the applicant, the sponsor and the Study Director describing deviations, if any,  ColonBroom nutrition from the GLP standards. Equipment shall have standard operating procedures (SOPs) describing their use, maintenance, and calibration. Deviations from the SOPs must be authorized by the Study Director. A Sponsor is required to notify the testing facility that the study must comply with the GLPs. Each study shall have a written Protocol describing the objectives and methods for the conduct of the study. You have one year from date of purchase to complete the course.
\ No newline at end of file